Thienemann M, Koran L M
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, CA 94305, USA.
J Neuropsychiatry Clin Neurosci. 1995 Spring;7(2):218-22. doi: 10.1176/jnp.7.2.218.
The authors examined 21 outpatients with obsessive-compulsive disorder for five neurological soft signs and abnormalities on two neuropsychological tests before and after 10 to 12 weeks of treatment with serotonin reuptake inhibitors. Patients showed a mean of 1.8 soft signs. Prevalences were finger-to-finger, 10%; adventitious movements, 29%; mirror movements, 33%; impaired cube drawing, 33%; and agraphesthesia, 76%. The Stroop Color and Word Test was abnormal in 10% and the Controlled Oral Word Association Test was abnormal in 14% of patients. Neither the presence of specific soft signs, the number of signs present, nor a combination of signs and test abnormalities predicted a poorer response to pharmacological treatment. Some baseline soft signs and abnormalities disappeared at endpoint in medication responders and nonresponders; no clear pattern of change emerged.
作者对21名强迫症门诊患者在使用血清素再摄取抑制剂治疗10至12周前后进行了五项神经学软体征检查以及两项神经心理学测试,以检测是否存在异常。患者平均有1.8项软体征。各软体征的发生率分别为:指指试验,10%;不自主运动,29%;镜像运动,33%;画立方体障碍,33%;皮肤书写觉障碍,76%。10%的患者在斯特鲁普颜色和文字测试中表现异常,14%的患者在受控口语联想测试中表现异常。无论是特定软体征的存在、软体征的数量,还是软体征与测试异常的组合,均无法预测药物治疗效果较差。在治疗终点时,一些基线软体征和异常在药物治疗有反应者和无反应者中均消失;未出现明显的变化模式。